Antibodies wane (major line of defense in nasal passage); may be more susceptible to mild re-infections (omicron); enduring immunity of T cells, ability of B cells to kick in, produce adaptive antibodies toward variants protects against severe disease leaps.org/how-long-do-co…
Because Omicron variant is latest, we have to examine whether T cells from vaccine or prior infection work well against it and this paper shows us they do! From NIAID & other institutions. Literally only ONE T cell epitope affected by the 32 mutations biorxiv.org/content/10.110…
"Virtually all individuals with existing anti-SARS-CoV-2 CD8+ T-cell responses should recognize Omicron". This study done in recovered but work in "vaccinees has demonstrated a strong CD4+ and CD8+ T-cell responses suggesting that similar trends" will be seen among vaccinated
Study from Pfizer verifying T cells from vax remain active against Omicron. When antibodies down "virus breaches defenses, cells become infected, that’s when T-cells come in, clear infected cells so they don’t keep replicating and become viral factories" theguardian.com/world/2021/dec…
An attempt to explain cellular immunity by @MichaelDaignau3 and me from real-world perspective on the ground. Cellular immunity will not prevent re-infections (mild) though; its impact is deeper washingtonpost.com/outlook/2021/1…
T cell paper: n=70 with J&J vs Pfizer vax vs those with COVID recovery. T cells provide protection across the Omicron spike protein (70-80% of CD4 & CD8 T cell response to spike maintained), same protection as with beta AND delta (despite more mutations) medrxiv.org/content/10.110…
Today a very nice article in Vox explaining T cells and B cells and antibodies; worth a read if you don't want to read the papers above since summarized really well vox.com/22878133/omicr…
Important paper to add to this thread. If you got Omicron on top of vaccine, you get broadly neutralizing antibodies but also T cells across whole virus so protects you against alpha, beta, gamma, delta (and zeta in future, immunity across whole virus) biorxiv.org/content/10.110…
Although have many said "we will all be exposed to Omicron" now since so transmissible, not everyone will; Covaxin booster great for those who didn't get during this time as 1) EUA pending, FDA; 2) whole inactivated virion virus so see whole virus
Why would whole inactivated virion (via Covaxin) booster be good if we don't get Omicron during this time of high transmission? Because you then form T cells across the entire virus - more than 1400 - so can combat variants in future sciencedirect.com/science/articl…
Breakthrough infections induce serum binding/ neutralizing antibody responses markedly more potent, durable and resilient to spike mutations observed in variants than those who received 2 doses of spike protein vax (may need whole virus vax) sciencedirect.com/science/articl…
Explains cellular immunity in a quick and thorough way. "The cells will save us". We expect antibodies to wane from vax (which is why boosters during Omicron surge helped) but the cellular memory stable at 450 days & counting and, importantly, adaptive nature.com/articles/d4158…
Good explanation of T cell response to SARS-CoV-2 from recent Nature Immunology article nature.com/articles/s4159…
Excellent recent article to add to cellular immunity vs antibody response to Omicron. Booster increased antibody responses which was needed in those who can't wait for memory B cells to make antibodies (older) but SARS-CoV-2-specific T-cells science.org/doi/10.1126/sc…
6 months after all vaccination regimens, with more consistent detection of specific CD4+ than CD8+ cells. No significant differences were detected between wild type & variant-specific CD4+ or CD8+ T-cell responses, including Omicron, indicating minimal escape at the T-cell level
Great article Science on cellular immunity, may help US on booster strategy "much focus in.. immunity surveillance has been on role of neutralizing antibodies..less emphasis on understanding role of T cells, memory B cells and non-neutralizing antibodies" science.org/doi/10.1126/sc…
"Mounting evidence (I would argue we have known about T cells for long time!) suggests T-cell contributions to the host immune response are required for early, broad, and durable protection from SARS-CoV-2, especially in the setting of new variants of concern"; T cells provide
durable protection Want T cells across whole virus? Give whole virus vaccine. "Because Covaxin shows immune system the entire virus, the vaccine elicits a broad immunologic response not only against spike, but also against the receptor-binding domain, the medpagetoday.com/opinion/second…
nucleocapsid protein of SARS-CoV-2, other parts of the virus. The vaccine also elicits strong cellular T-cell mediated immune responses, vital for long-term protection". Excellent tweet @profshanecrotty -multiple layers of protection in immune system
Cell paper focuses on durability of memory B cells: NO evidence of decay >9 months post vaccination. Boost will reactivate B cells to make antibodies, not needed if you already have high antibodies (eg 4th dose); breakthrough- same increase in Abs as boost cell.com/cell/fulltext/…
As US debates 4th shot, ? comes up whether even 3rd shot makes B cells longer lasting; above paper did not show that. Below paper on T cells >80: 3rd shot increases antibodies but "CD4 T-cell frequencies reached similar levels after two and three doses " thelancet.com/journals/lanin…
Important article that shows that every vaccination or exposure to COVID-19 expands and diversifies T cells nature.com/articles/s4159…
Recent article about Omicron (>=32 mutations in spike) in vax'd: "despite mutations in spike protein, Omicron recognized by cellular component of immune system.. reasonable to assume protection from hospitalization and severe disease will be maintained" jamanetwork.com/journals/jaman…
Please remember cellular immunity is not just T cells but also B cells- they produce antibodies if virus seen again aided by T cells but the antibodies are adapted to the variant they see in front of them
Question on whether variant-specific booster needed in future; study in above thread in macaques showed 3rd shot with "old" vaccine stimulated B cells & protected macaques to same extent as getting Omicron-specific booster due to B cells. New paper here: nature.com/articles/s4158…
3rd shot (boost) increases frequency of Omicron-receptor binding domain (RBD) binding memory B cells, a site on spike protein that is more conserved across variants (part that sticks to cell). So, 3rd shot stimulates B cells that work across parts of virus same in all variants
Epidemiologically, we saw 3rd shot of great benefit to older individuals in terms of protection against severe disease during Omicron in this large VA study
This is why 4th shot likely will be needed for older individuals (and immunocompromised) in late summer to prepare for seasonal fall/winter respiratory pathogen season to protect these populations against severe disease washingtonpost.com/outlook/2022/0…
If you read these long threads on cellular immunity, the ability of vaccines to prevent severe disease with COVID will become more clear; which is a HUGE benefit of vaccines
Amazing paper @SetteLab Cell today comparing cohorts Pfizer, Moderna, AztraZeneca, Novavax 1) 100% mRNA/Novavax vaccinees made CD4 cells 2) mRNA/AZ vaccinees similar % CD8 cells 3) Infection or AZ inc memory B cells 4) Antibodies wane; B/T cells stable cell.com/cell/fulltext/…
CD4 and CD8 are T cells against SARS-CoV-2 and memory B cells being stimulated help produce more antibodies. Antibodies waning (or not working as well against variants) happening but preservation of B/T cells generated by vaccination very heartening leaps.org/how-long-do-co…
Saw article yesterday -those with previous infection didn't have T cell response broadened by Omicron?Sample size tiny (6 prior Wuhan Hu-1 infection). Doesn't negate huge body of research on cellular immunity above. New test for cellular immunity below! nature.com/articles/s4158…
The profound decoupling between cases & severe disease at this stage of the pandemic is mainly due to cellular immunity (for instance, Chicago has had zero COVID deaths June 6-10: chicago.gov/city/en/sites/…; Marin none since March) - B cells
T cells here:
Nice review why T cells so important to combat variants: "As we adapt to coexist with SARS-CoV-2"..need T cell assays. 1 large study (n=3000) w/ T-SPOT Discovery SARS-CoV-2 assay shows SARS-CoV-2–reactive T cells protect from COVID & last long time science.org/doi/10.1126/sc…
This article explains why - even with BA4/BA5- rates of severe disease staying lower than any time since March '20 across much of the world due to cellular immunity @Medscape medscape.com/viewarticle/97…
Although above cellular immunity thread has good papers, this review @profshanecrotty great (see figure). 1) Hybrid immunity strongest of all (if haven't had covid, hopefully #covaxin whole virus vax coming; 2) T/B cells last long from infection or vax onlinelibrary.wiley.com/doi/10.1111/im…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Breakthrough infection by SARS-CoV-2 Delta and Omicron variants elicited immune response comparable to mRNA booster vaccination academic.oup.com/jid/advance-ar…
Adds to other studies showing an infection after vaccination serves as a booster of the immune response (of antibodies, T and B cells) like this one from Yale and others in the thread below: mdlinx.com/news/booster-a…
Other studies here:
T CELLS: In fact, this important paper shows that any exposure (breakthrough infection) or any booster after vaccination actually broadens and diversifies the T cell memory repertoire (e.g. expands your immune response). nature.com/articles/s4159…
UK also has good data #monkeypox. With limited US vax supply, would 1) hold for now in those who had smallpox vax (<1970 born); 3) target those w/ multiple sex partners; 4) Give 1 dose for now (like urged with limited COVID vax at start); 4) Boost supply
US apparently rejected Jynneos doses from Denmark since FDA didn't inspect but EU did & says high quality- would trust EU CDC-very good!
Beyond strategies above, here is a background on monkeypox:
BA4/BA5 SUBVARIANTS: 2-dose Pfizer vaccine 87% protective against hospitalizations with these 2 subvariants in large S. Africa study. High protection against severe disease across variants/subvariants is due to cellular immunity (B/T cells) discussed often bloomberg.com/news/articles/…
Natural infection pre-Omicron also provides strong protection against severe disease & death (97.3%) from circulating Omicron subvariants like BA4/BA5. Despite multiple mutations across spike protein in subvariants, T cells still cover multiple epitopes medrxiv.org/content/10.110…
T cells (prevent severe disease) line up across spike protein on multiple parts or "epitopes"; even with >32 mutations across spike protein with Omicron, still have >60 T cells from vaccine on spike. BA4/BA5 booster ready by Oct to prevent mild infections investors.biontech.de/news-releases/…
RAMSEY HUNT SYNDROME: What is this? Caused by varicella zoster virus, which is a herpes DNA virus (SARS-CoV-2 is an RNA virus). DNA viruses can stay in your body (hiding out in what are called "dorsal root ganglion"; nerves) after initial infection & come back. RNA viruses don't
generally stay in your body. Viruses like HIV are "retroviruses" which means their genetic material is RNA but it converts to DNA in the human host and will then stay in the body by intercalating that DNA into the human host chromosome. So, varicella zoster virus (VZA) is agent
of chickenpox in children although we now vaccinate (although many of us who are older had chickenpox as children and considered immune for long time). Even if had chickenpox as child, that virus can hide out in body & come back as "shingles" or zoster. Ramsey Hunt syndrome is
Lowest COVID death rate below in spring 2022 predicted by multiple modelers due to vaccines and high rates of Omicron-infused immunity in the world by this date. COVID is never over. As a non-eradicable virus, will need constant management by medical system. WHO plan here:
How do we manage COVID if noneradicable? in US, therapeutics, Evusheld, vaccines. Need global equity. HARM REDUCTION means reducing effects of pathogen but considering needs of society & individuals in context of pathogen- applies to HIV, COVID, monkeypox
Pandemic preparedness from a vaccinology standpoint needs ongoing commitment. Wonderful paper by Drs. Sullivan and @BarneyGrahamMD in Nature Immunology in 2018 nature.com/articles/s4159…
Latest blog for @Medscape on Novavax and Covaxin vaccines (and even more vaccines for COVID needed in future including nasal vaccines); timely to discuss given that the FDA advisory meeting for Novavax EUA is tomorrow June 7, 2022 medscape.com/viewarticle/97…
@Medscape 2 major reasons listed in @Medscape blog for Novavax: 1) may increase uptake; 2) booster shot after mRNA vaccines: seems that mixing vaccines boosts broader response since - although all vaccines have spike- seem to generate different in vivo responses: nature.com/articles/s4154…
This UK study in the Lancet did study Novavax as a booster after mRNA vaccines (specifically Pfizer) - Novavax given as a half-dose & full dose (and also following AztraZeneca). NVX boosted T cells more if prior vaccine was AztraZeneca (than Pfizer) thelancet.com/journals/lance…